Podcasts Health & Fitness Medicine NEJM Interviews NEJM Interview: Dr. Brendan Saloner on increasing access to medication for treatment of opioid use disorder.

NEJM Interview: Dr. Brendan Saloner on increasing access to medication for treatment of opioid use disorder.

Published: July 4, 2018, 3:01 p.m.

b'Dr. Brendan Saloner is an assistant professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. B. Saloner, K.B. Stoller, and G.C. Alexander. Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment. N Engl J Med 2018;379:4-6. S.E. Wakeman and M.L. Barnett. Primary Care and the Opioid-Overdose Crisis - Buprenorphine Myths and Realities. N Engl J Med 2018;379:1-4. J.H. Samet, M. Botticelli, and M. Bharel. Methadone in Primary Care - One Small Step for Congress, One Giant Leap for Addiction Treatment. N Engl J Med 2018;379:7-8.'